NEW YORK (GenomeWeb News) – N-of-One and Appistry said today that they have signed an agreement to jointly provide genetic sequence data analysis and molecular interpretation services.

Specifically, both companies will market N-of-One’s interpretation services and content together with Appistry’s bioinformatics next-generation sequencing analysis solutions and services. Bringing their offerings together will provide a complete workflow that will support diagnostic labs, healthcare providers, and other healthcare organizations, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.